Sigyn Therapeutics, Inc. (SIGY) › Net IncomeSigyn Therapeutics, Inc. (SIGY) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$387.5K2015: -$2.69M2017: -$4.25M2018: -$2.62M2019: -$3.07M2020: -$1.26M2021: -$3.00M2022: -$2.93M2023: -$4.15M2024: -$3.34M-$3.34M2014Net Income (USD)2024Fiscal YearNet IncomeChange YoY2024-$3.34M+19.4%2023-$4.15M-41.5%2022-$2.93M+2.5%2021-$3.00M-138.5%2020-$1.26M+59.0%2019-$3.07M-17.3%2018-$2.62M+38.4%2017-$4.25M—2015-$2.69M-595.2%2014-$387.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share